Orestrate Explained

Orestrate, also known as estradiol 3-propionate 17β-(1-cyclohexenyl) ether, is an estrogen medication and estrogen ester which was never marketed.^{[1] [2] [3] [4] [5]} It is the C3 propionate ester and C17β-(1-cyclohexenyl) ether of estradiol.

See also

• List of estrogen esters § Esters of steroidal estrogens

Notes and References

1. Book: Elks J . The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. 14 November 2014. Springer. 978-1-4757-2085-3. 898, 905.
2. Gardi R, Vitali R, Falconi G, Ercoli A . 1,3,5(10)-Estratrien-17 -yl enol ethers and acetals. New classes of orally and parenterally active estrogenic derivatives . Journal of Medicinal Chemistry . 16 . 2 . 123–127 . February 1973 . 4683106 . 10.1021/jm00260a009 .
3. Galletti F, Gardi R . Effect of two orally active estradiol derivatives on sulfobromphthalein retention in rats . Pharmacological Research Communications . 6 . 2 . 135–145 . April 1974 . 4438394 . 10.1016/s0031-6989(74)80021-4 .
4. Book: List PH, Hörhammer L . Orestratum . Chemikalien und Drogen Teil A: N-Q. https://books.google.com/books?id=4TWnBgAAQBAJ&pg=PA331 . 12 March 2013. Springer-Verlag. 978-3-642-65035-2. 331–.
5. Book: Roche EB, ((Academy of Pharmaceutical Sciences, ((Medicinal Chemistry Section)) . Design of biopharmaceutical properties through prodrugs and analogs: a symposium. 1977. The Academy. 978-0-917330-16-2. 7.